Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × Bortezomib × Clear all

NCT00023712 2019-07-30

Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Phase 2 Completed

58 enrolled 14 charts

Carcinoma, Ovarian Epithelial